Aqr Capital Management LLC Solid Biosciences Inc. Transaction History

Aqr Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $67,988 - $196,060	-158,113 Reduced 42.97%	209,818 $129,000
Q1 2022 May 16, 2022	BUY	$0.74 - $1.79 $230,317 - $557,119	311,240 Added 549.01%	367,931 $442,000
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $105,466 - $153,518	-62,406 Reduced 52.4%	56,691 $99,000
Q3 2021 Nov 15, 2021	SELL	$2.38 - $3.77 $241,631 - $382,753	-101,526 Reduced 46.02%	119,097 $285,000
Q2 2021 Aug 16, 2021	BUY	$3.49 - $5.51 $208,611 - $329,354	59,774 Added 37.16%	220,623 $807,000
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $863,759 - $1.72 Million	160,849 New	160,849 $889,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $11.64 $191,788 - $515,570	-44,293 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $203,747 - $448,688	44,293 New	44,293 $255,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $24.3M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.